
Waters Corporation WAT
€ 284.64
-0.56%
Quartalsbericht 2026-Q1
hinzugefügt 12.05.2026
Land |
|
IPO-Jahr |
1995 |
Branche |
Diagnostik & Forschung |
Börse |
NYSESPB |
Anteile |
59.5 M |
Marktkapitalisierung |
$ 19.7 B |
EBITDA (LTM) |
$ 602 M |
P/E (LTM) |
57.36 |
P/S (LTM) |
5.99 |
EPS (LTM) |
6.14 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
$ 17.26 | -7.0 % | $ 181 M | Nasdaq Global Market | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Co-Diagnostics
CODX
|
$ 1.34 | -17.79 % | $ 1.78 M | Nasdaq Capital Market | ||
|
Fulgent Genetics
FLGT
|
$ 15.78 | -2.53 % | $ 477 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 112.09 | -1.02 % | $ 34.1 B | NYSE,SPB | ||
|
Castle Biosciences
CSTL
|
$ 19.05 | 0.9 % | $ 552 M | Nasdaq Global Market,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 139.97 | -2.28 % | $ 22.3 B | Nasdaq Global Select Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.8 | -5.26 % | $ 7.96 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 19.83 | -3.22 % | $ 1.06 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 94.74 | -2.0 % | $ 6.39 B | Nasdaq Global Select Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Medpace Holdings
MEDP
|
$ 419.82 | 0.16 % | $ 12.1 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 043.89 | 0.19 % | $ 21.5 B | NYSE,SPB | ||
|
Myriad Genetics
MYGN
|
$ 3.6 | -0.69 % | $ 333 M | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
NeoGenomics
NEO
|
$ 8.28 | -0.96 % | $ 1.06 B | Nasdaq Global Select Market,SPB | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.46 | -2.48 % | $ 413 M | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 157.18 | -1.33 % | $ 7.79 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 186.22 | -5.43 % | $ 18.3 B | Nasdaq Global Select Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Koninklijke Philips N.V.
PHG
|
$ 25.27 | -0.94 % | $ 24 B | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Guardant Health
GH
|
$ 92.95 | -5.79 % | $ 11.7 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 5.73 | -1.55 % | $ 239 M | NYSE American | ||
|
Personalis
PSNL
|
$ 6.47 | -3.64 % | $ 577 M | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 117.95 | 0.73 % | $ 9.73 B | Nasdaq Global Select Market,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 52.99 | -0.01 % | $ 2.69 B | Nasdaq Capital Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Twist Bioscience Corporation
TWST
|
$ 49.3 | -6.89 % | $ 2.95 B | Nasdaq Global Select Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.31 | -4.04 % | $ 5.31 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 251.18 | -1.12 % | $ 20.9 B | NYSE,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 439.31 | -1.97 % | $ 166 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.57 | -1.49 % | $ 205 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 134.9 | 0.13 % | $ 6.31 B | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 8.27 | -1.9 % | $ 1.79 B | Nasdaq Global Select Market,SPB |